Effect of radiation dosage to vital ocular structures on visual outcomes: Re-evaluation for the future [0.03%]
放射剂量对重要眼部结构的影响及其对未来视力结果的再评估
Lauren B Yeager,Emmanouil Tsamis,Matthew Bompastore et al.
Lauren B Yeager et al.
Objective: To explore the impact of radiation dosage on vital ocular structures to identify target dosage for vision preservation in patients with uveal melanoma treated with Eye Physics plaque brachytherapy. ...
Treatment and outcomes of primary urethral cancer treated with radiation therapy [0.03%]
放射治疗原发性尿道癌的疗效及预后分析
Benjamin D Hopkins,David C Qian,Tony Y Eng et al.
Benjamin D Hopkins et al.
Background: Primary urethral cancer (PUC) is a heterogeneous and aggressive malignancy that accounts for less than 1% of all genitourinary malignancies. Due to its rarity, no prospective data exists to guide treatment par...
Patterns of anesthesia(AS) and analgesia(AG) practice in gynecological brachytherapy in India [0.03%]
印度妇科近距离放射治疗中麻醉和镇痛实践的现状及对策分析模式
Pratiksha Tyagi,Amanda Rivera,Santam Chakraborty et al.
Pratiksha Tyagi et al.
Purpose: Fractionated HDR brachytherapy, following external beam radiotherapy, is essential for treating locally advanced cervical cancer. Modern techniques enable the delivery of multiple fractions with a single applicat...
Improved outcomes in primary hepatocellular carcinoma adjacent to large vessels: A combined approach of MRI-guided radiofrequency ablation and 125I implantation [0.03%]
磁共振引导下射频消融联合碘-125粒子植入治疗大血管旁原发性肝癌疗效观察
Xianhua Miao,Rui Guo,Qingfeng Lin et al.
Xianhua Miao et al.
Purpose: To assess the clinical efficacy and feasibility of combining MRI-guided radiofrequency ablation (RFA) with 125I seed brachytherapy for hepatocellular carcinoma (HCC) adjoining large vessels (≥3 mm diameter). ...
Towards robust deep learning-based autosegmentation in MRI-planned gynecological brachytherapy: Importance of scalable development and comprehensive evaluation [0.03%]
基于深度学习的MRI妇科近距离放射治疗自动勾画的稳健性研究：可扩展开发和全面评估的重要性
Patricia Jule Oliva,Shrimanti Ghosh,Fleur Huang et al.
Patricia Jule Oliva et al.
Purpose: To present comprehensive development and evaluation methodologies for a generalizable deep learning (DL)-driven autocontouring model of standard pelvic organs-at-risk (OARs) in MRI-planned cervical brachytherapy....
MRI-guided neurovascular bundle avoidance in high dose rate prostate brachytherapy [0.03%]
磁共振引导的高剂量率前列腺组织间照射中神经血管束避让技术
Drew G Gerber,Sean Dresser,Xiaofeng Yang et al.
Drew G Gerber et al.
Purpose: The neurovascular bundles (NVBs) play a role in erectile function and are not well visualized on ultrasound or computed tomography (CT). In this study we hypothesize that treatment planning MRI will allow avoidan...
A review on the transition from PDR to HDR brachytherapy (interventional radiotherapy) for treatment of head and neck cancer: Clinical and practical aspects [0.03%]
HDR腔内近距离放射治疗头颈肿瘤的临床与实践进展综述
Renske van Noortwijk,Petra Kroon,Maarten Kastelijns et al.
Renske van Noortwijk et al.
Purpose: To increase knowledge on clinical outcomes of pulsed-dose-rate (PDR) and high-dose-rate (HDR) brachytherapy (BT) (also referred to as Interventional Radiotherapy (IRT)) treatments for superficial head and neck ca...
Prospective study on tumor control, survival, toxicity and quality of life after EBRT and an HDR-brachytherapy boost in intermediate to high-risk prostate cancer patients [0.03%]
根治性外照射放疗联合高剂量率组织间后装补量放疗治疗中高危前列腺癌患者疗效及生活质量的前瞻性研究
Max Peters,Tonnis T Nuver,Marnix J A Rasing et al.
Max Peters et al.
Introduction: Brachytherapy boost improves biochemical disease-free survival (bDFS) for intermediate/high-risk prostate cancer, but may increase toxicity. We prospectively assessed tumor control, survival, toxicity, and q...
Ultrasound and CT-guided 125I implantation combined with TACE therapy in the treatment of recurrent HCC after RFA [0.03%]
超声和CT引导下125I粒子植入联合TACE治疗射频消融后复发的肝癌患者
Ningjie Li,Ping Yang,Jun Fang et al.
Ningjie Li et al.
Purpose: This study aimed to evaluate the efficacy and safety of combining transarterial chemoembolization (TACE) with 125Iodine (125I) seed implantation for the treatment of recurrent hepatocellular carcinoma (HCC) follo...
Randomized trial of dose de-escalation in low-risk prostate cancer patients implanted with Pd-103 [0.03%]
低危前列腺癌患者钯-103粒子植入后剂量递减的随机对照试验研究
Martin King,Grgur Mirić,Mutlay Sayan et al.
Martin King et al.
Background: Palladium-103 (Pd-103) brachytherapy has been associated with excellent oncologic outcomes for favorable risk prostate cancer. Our purpose was to evaluate whether de-escalated dose Pd-103 was associated with a...